SEARCH

SEARCH BY CITATION

References

  • 1
    Boosinger TR, Zerbe CA, Grabau JH, et al. Multihormonal pancreatic endocrine tumor in a dog with duodenal ulcers and hypertrophic gastropathy. Vet Pathol 1988; 25:237239.
  • 2
    Gabbert NH, Nachreiner RF, Holmes-Wood P., et al. Serum immunoreactive gastrin concentrations in the dog: Basal and postprandial values measured by radioimmunoassay. Am J Vet Res 1984; 45:23512353.
  • 3
    Pappas TN, Yovos JG, Ellison EC, et al. Pancreatic polypeptide in acute pancreatitis and small-bowel infarction in dogs. Dig Dis Sci 1981; 26:10131018.
  • 4
    Kruth SA, Feldman EC, Kennedy PC, et al. Insulin-secreting islet cell tumors: Establishing a diagnosis and the clinical course for 25 dogs. J Am Vet Med Assoc 1982; 181:5458.
  • 5
    Mehlaff CJ, Peterson ME, Patnaik AK, et al. Insulin-producing islet cell neoplasms: Surgical considerations and general management in 35 dogs. J Am Vet Med Assoc 1985; 21:607612.
  • 6
    Leifer CE, Peterson ME, Matus RE. Insulin-secreting tumor: Diagnosis and medical and surgical management in 55 dogs. J Am Vet Med Assoc 1986; 188:6064.
  • 7
    Drazner FH. Canine gastrinoma: A condition analogous to the Zollinger-Ellison syndrome in man. California Veterinarian 1981; 11:611.
  • 8
    Jones BR, Nicholls MR, Badman R. Peptic ulceration in a dog associated with an islet cell carcinoma of the pancreas and an elevated plasma gastrin level. J Small Anim Pract 1976; 17:593598.
  • 9
    Straus E., Johnson GF, Yalow RS, et al. Canine Zollinger-Ellison syndrome. Gastroenterology 1977; 72:380381.
  • 10
    Happé RP, van der Gaag I., Lamers CBHW, et al. Zollinger-Ellison syndrome in three dogs. Vet Pathol 1980; 17:177186.
  • 11
    O'Brien TD, Hayden DW, O'Leary TP, et al. Canine pancreatic endocrine tumors: Immunohistochemical analysis of hormone content and amyloid. Vet Pathol 1987; 24:308314.
  • 12
    Hawkins KL, Summers BA, Kuhajda FP, et al. Immunocytochemistry of normal pancreatic islets and spontaneous islet cell tumors in dogs. Vet Pathol 1987; 24:170179.
  • 13
    Moore FM, Dayal Y., Shelton JC. Pancreatic endocrine tumors in dogs: An immunohistochemical analysis (abstract). Lab Invest 1985; 52:44A45A.
  • 14
    Bestetti G., Rossi GL. Islet cell carcinomas in dogs. Virchows Arch [A] 1985; 405:203214.
  • 15
    Forssmann WG, Helmstaedter V., Metz J., et al. The identification of the F-cell in the dog pancreas as the pancreatic polypeptide producing cell. Histochemistry 1977; 50:281290.
  • 16
    Adrian TE, Uttenthal LO, Williams SJ, et al. Secretion of pancreatic polypeptide in patients with pancreatic endocrine tumors. N Engl J Med 1986; 315:287291.
  • 17
    Friesen SR, Tomita T., Kimmel JR. Pancreatic polypeptide update: Its roles in detection of the trait of multiple endocrine adenopathy syndrome, type I and pancreatic polypeptide-secreting tumors. Surgery 1983; 94:10281037.
  • 18
    Tomita T., Friesen SR, Kimmel JR, et al. Pancreatic polypeptide-secreting islet-cell tumors. A study of three cases. Am J Pathol 1983; 113: 134142.
  • 19
    Bordi C., Togni R., Baetens D., et al. Human islet cell tumor storing pancreatic polypeptide: A light and electron microscopic study. J Clin Endocrinol Metab 1978; 46:215219.
  • 20
    Larsson LI, Schwartz T., Lundqvist G. Occurrence of human pancreatic polypeptide in pancreatic endocrine tumors. Am J Pathol 1976; 85:675682.
  • 21
    Tomita T., Kimmel JR, Friesen SR, et al. Pancreatic polypeptide cell hyperplasia with and without watery diarrhea syndrome. J Surg Oncol 1980; 14:1120.
  • 22
    Jenkins TW, Sacks HS, O'Dorisio TM, et al. Medullary carcinoma of the thyroid, pancreatic nesidioblastosis and microdenosis, and pancreatic polypeptide hypersecretion: A new association and clinical hormonal responses to long-acting somatostatin analog SMS 201–995. J Clin Endocrinol Metab 1987; 64:13131319.
  • 23
    Taylor IL, Solomon TE, Walsh JH, et al. Pancreatic polypeptide metabolism and effect on pancreatic secretion in dogs. Gastroenterology 1979; 76:524428.
  • 24
    Beglinger C., Taylor IL, Grossman MI, et al. Pancreatic polypeptide inhibits exocrine pancreatic responses to six stimulants. Am J Physiol 1984; 246:242246.
  • 25
    Lin T., Chance R. Spectrum of gastrointestinal actions of bovine. In: BloomSR, ed.. Gut Hormones. Edinburgh : Churchill Livingstone, 1978; 242246.
  • 26
    Parks DL, Gingerich RL, Jaffe BM, et al. Role of pancreatic polypeptide in canine gastric acid secretion. Am J Physiol 1979; 236:E488E494.
  • 27
    Bueno L., Fioramonti J., Rayner V., et al. Effects of motilin, somatostatin and pancreatic polypeptide on the migrating myoelectric complex in pig and dog. Gastroenterology 1982; 82:13951402.
  • 28
    Hall KE, Diamant NE, El-Sharkawy TV, et al. Effect of pancreatic polypeptide on canine migrating motor complex and plasma motilin. Am J Physiol 1983; 245:G178G185.
  • 29
    Lin T., Evans DC, Chance RE, et al. Bovine pancreatic polypeptide: Action on gastric and pancreatic secretion in dogs. Am J Physiol 1977; 232:E311E315.
  • 30
    Walsh JH. Gastrointestinal hormones. In: JohnsonLR, ed.. Physiology of the Gastrointestinal Tract. New York : Raven, 1987; 204246.
  • 31
    Jensen RT, Gardner JD, Raufman J-P, et al. Zollinger-Ellison syndrome: Current concepts and management. Ann Intern Med 1983; 98:5975.
  • 32
    Malagelada J-R, Davis CS, O'Fallon WM, et al. Laboratory diagnosis of gastrinoma I. A prospective evaluation of gastric analysis and fasting serum gastrin levels. Mayo Clin Proc 1982; 57: 211218.
  • 33
    Malagelada J-R, Glanzman SL, Go VL. Laboratory diagnosis of gastrinoma. II. A prospective study of gastrin challenge tests. Mayo Clin Proc 1982; 57: 219226.
  • 34
    Romanus ME, Neal JA, Dilley WG, et al. Comparison of four provocative tests for the diagnosis of gastrinoma. Ann Surg 1983; 197:608617.
  • 35
    Barbezat GO, Daniel M., Bank S., et al. Effect of histamine H2-receptor blockade on fasting serum gastrin and fasting gastric acid secretion in the dog. Nature 1974; 249:666668.
  • 36
    Carter DC, Forrest JAH, Logan RA, et al. Effect of H2-receptor antagonist, cimetidine, on gastric secretion and serum gastrin during insulin infusion in man. Scand J Gastroenterol 1976; 11:565570.
  • 37
    Bank S., Barbezat GA, Vinik AI, et al. Serum gastrin levels before and after 6 weeks of cimetidine therapy in patients with duodenal ulcer. Digestion 1977; 15:157161.
  • 38
    Taylor DC, Cresswell PR, Bartlett DC. The metabolism and elimination of cimetidine, a histamine H2-receptor antagonist, in the rat, dog, and man. Drug Metab Dispos 1978: 6:2130.